Benefits and limitations of different study designs for long-acting antiretroviral therapy among people living with HIV with viremia.

Authors:
Gandhi M; Nachega J; Miller V; Wilkin T.

Journal:
J Int AIDS Soc

Publication Year: 2023

DOI:
10.1002/jia2.26093

PMCID:
PMC10338993

PMID:
37439071

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Int AIDS Soc

Abbreviation: J Int AIDS Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advanced disease programming brings much needed attention and improvements to inpatient paediatric …
Buck WC; Schindele A; Taibo E and 6 more (2024) - Transparency Score: 3/6
HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender a…
Watson DL; Listerud L; Drab RA and 3 more (2024) - Transparency Score: 3/6
Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowled…
Bromberg DJ; Machavariani E; Madden LM and 8 more (2024) - Transparency Score: 3/6
Long-term retention on antiretroviral treatment after enrolment in prevention of vertical HIV trans…
Urrio RF; Lyatuu GW; Sando D and 14 more (2024) - Transparency Score: 3/6
My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual…
Haberer JE; Oware K; Juma L and 9 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS None of the authors reports any relevant competing interests."

Evidence found in paper:

"MG was funded by NIAID/NIH 3R01AI098472 (PI Gandhi). Data is available from this viewpoint upon request."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025